Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORVETTE-01 ivermectin in mild COVID-19
jRCT2031200120Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Ivermectin with Placebo (2 arms). Primary endpoint: Time to negative SARS-CoV-2 PCR. Started Oct 2020; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031200120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200120.